DES or BMS? No Mortality Difference

ACC Conference Reporter

ESC Congress 2016 | ROME — Six years after treatment, there was no difference in outcome for patients who received second generation drug-eluting stents (DES) versus those who received bare metal stents (BMS), a finding that appears to confirm the safety of DES. Read More >>>

Keywords: ESC Congress

< Back to Listings